Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Amortization - Intangibles (2023 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Amortization - Intangibles for 2 consecutive years, with $316000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Intangibles fell 80.45% year-over-year to $316000.0, compared with a TTM value of $3.9 million through Dec 2025, down 38.06%, and an annual FY2025 reading of $3.9 million, down 38.06% over the prior year.
  • Amortization - Intangibles was $316000.0 for Q4 2025 at Zevra Therapeutics, roughly flat from $315000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.6 million in Q4 2024 and bottomed at $315000.0 in Q3 2025.